<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Moreover Technologies - Biotech news - 30 of 7736 returned</title>
    <link>http://www.moreover.com/rss</link>
    <description>Moreover Technologies - Real-time news and blogs from thousands of sources</description>
    <language>en-us</language>
    <image>
      <title>Moreover Technologies</title>
      <url>http://i.moreover.com/pics/rss.gif</url>
      <link>http://www.moreover.com/rss</link>
      <width>144</width>
      <height>16</height>
      <description>Moreover Technologies - Premier purveyor of real-time news and RSS feeds from across the Web</description>
    </image>
    <item>
      <title>AutoZone Official Site - Sponsored Link</title>
      <link>http://context4.kanoodle.com/cgi-bin/rss_query_image.cgi?a=click&amp;bid_id=92187347&amp;creative=234228&amp;clickid=87877635&amp;format=xml1&amp;cgroup=biotechnews&amp;query=business&amp;ts=ad20091120120000</link>
      <description>Ad - Check Store Pricing &amp; Availability. Visit AutoZone's Official Site Now</description>
      <guid isPermaLink="false">ad20091120120000</guid>
      <pubDate>Fri, 20 Nov 2009 18:36:00 GMT</pubDate>
    </item>
    <item>
      <title>Linkage Biosciences Unveils New Tool for Immunogenetic Testing</title>
      <link>http://c.moreover.com/click/here.pl?r2348381270</link>
      <description>, a privately held molecular diagnostics company, recently unveiled LinkSeq a new one-step method for Human Leukocyte Antigen (HLA) testing at the annual meeting of the American Society of Histocompatibility and Immunogenetics (ASHI) in San Francisco.</description>
      <guid>http://c.moreover.com/click/here.pl?r2348381270</guid>
      <pubDate>Fri, 20 Nov 2009 18:36:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Clinical%20Lab%20Products&amp;o=rss002">Clinical Lab Products</source>
    </item>
    <item>
      <title>UPDATE 1-HealthCor slams Biogen CEO for outsize pay package</title>
      <link>http://c.moreover.com/click/here.pl?r2348368693</link>
      <description>In a letter to CEO James Mullen and the company's board, HealthCor criticized what it says is a disconnect between Mullen's compensation and Biogen's stock performance. Shares of Biogen, which makes the multiple sclerosis drugs Avonex and Tysabri, are</description>
      <guid>http://c.moreover.com/click/here.pl?r2348368693</guid>
      <pubDate>Fri, 20 Nov 2009 18:30:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Interactive%20Investor%20International&amp;o=rss002">Interactive Investor International</source>
    </item>
    <item>
      <title>UPDATE 1-HealthCor slams Biogen CEO for outsize pay package</title>
      <link>http://c.moreover.com/click/here.pl?r2348366744</link>
      <description> BOSTON, Nov 20 (Reuters) - In a letter to CEO James Mullen and the company's board, HealthCor criticized what it says is a disconnect between Mullen's compensation and Biogen's stock performance. Shares of Biogen, which makes the multiple sclerosis</description>
      <guid>http://c.moreover.com/click/here.pl?r2348366744</guid>
      <pubDate>Fri, 20 Nov 2009 18:30:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Forbes.com&amp;o=rss002">Forbes.com</source>
    </item>
    <item>
      <title>NSF awards $7.5M grant to University of Oklahoma for plant genomics</title>
      <link>http://c.moreover.com/click/here.pl?r2348357433</link>
      <description>A decade ago, a group of University of Oklahoma researchers were sequencing the first human chromosome as part of the human genome project. Today, the OU Advanced Center for Genome Technology is contributing to an international effort to sequence the</description>
      <guid>http://c.moreover.com/click/here.pl?r2348357433</guid>
      <pubDate>Fri, 20 Nov 2009 18:26:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=EurekAlert%21&amp;o=rss002">EurekAlert!</source>
    </item>
    <item>
      <title>HealthCor Urges Biogen Board Consider Number Of Changes (DJ)</title>
      <link>http://c.moreover.com/click/here.pl?r2348355679</link>
      <description>By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- HealthCor Management, a hedge fund that owns a 1.3% stake in Biogen Idec Inc. (BIIB), sent a letter to the biotech's board criticizing its spending, executive compensation and urging it to</description>
      <guid>http://c.moreover.com/click/here.pl?r2348355679</guid>
      <pubDate>Fri, 20 Nov 2009 18:25:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Easy%20Bourse&amp;o=rss002">Easy Bourse</source>
    </item>
    <item>
      <title>UPDATE 1-HealthCor slams Biogen CEO for outsize pay package</title>
      <link>http://c.moreover.com/click/here.pl?r2348355593</link>
      <description>slams Biogen CEO for outsize pay package Reuters addImpression('7006865_225x90 RW [r] Your guide to the capital jungle adsrc 'reuters.com.dart/bizfinance/industries/healthcare/article;' ( typeof(AD_TRACKER) 'undefined' AD_TRACKER.globalAdSrcType null )</description>
      <guid>http://c.moreover.com/click/here.pl?r2348355593</guid>
      <pubDate>Fri, 20 Nov 2009 18:25:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Reuters&amp;o=rss002">Reuters</source>
    </item>
    <item>
      <title>Scientists complete corn genome</title>
      <link>http://c.moreover.com/click/here.pl?r2348315789</link>
      <description> After three years and $30 million, U.S. scientists have finished mapping the complete genome sequence of corn, the most widely eaten cereal after rice. A strain of corn called B73 may prove to be a textbook of how genes work, said Patrick Schnable, a</description>
      <guid>http://c.moreover.com/click/here.pl?r2348315789</guid>
      <pubDate>Fri, 20 Nov 2009 18:09:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=UPI&amp;o=rss002">UPI</source>
    </item>
    <item>
      <title>Biotech Import Ban Creates Feed Ingredient Shortage in Turkey</title>
      <link>http://c.moreover.com/click/here.pl?r2348313895</link>
      <description>In the weeks following Turkey's announcement of additional requirements on importation of all food and feed products containing genetically enhanced components, progress to reverse or amend the stringent requirements has yet to be made. Those involved in</description>
      <guid>http://c.moreover.com/click/here.pl?r2348313895</guid>
      <pubDate>Fri, 20 Nov 2009 18:08:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=USAgNet&amp;o=rss002">USAgNet</source>
    </item>
    <item>
      <title>HealthCor Urges Biogen Board Consider Number Of Changes</title>
      <link>http://c.moreover.com/click/here.pl?r2348294014</link>
      <description>NEW YORK -(Dow Jones)- HealthCor Management, a hedge fund that owns a 1.3% stake in Biogen Idec Inc. (BIIB), sent a letter to the biotech's board criticizing its spending, executive compensation and urging it to return cash to shareholders. The fund,</description>
      <guid>http://c.moreover.com/click/here.pl?r2348294014</guid>
      <pubDate>Fri, 20 Nov 2009 17:59:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Morningstar.com&amp;o=rss002">Morningstar.com</source>
    </item>
    <item>
      <title>New Bench Top Sequencer Offers Significant Improvements to the Genome Sequencer FLX System</title>
      <link>http://c.moreover.com/click/here.pl?r2348291945</link>
      <description>454 Life Sciences, a Roche Company, announced today at the Association of Molecular Pathology Annual Meeting in Kissimmee, Florida a series of revolutionary developments which significantly expand the company’s high-throughput sequencing portfolio.</description>
      <guid>http://c.moreover.com/click/here.pl?r2348291945</guid>
      <pubDate>Fri, 20 Nov 2009 17:56:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Select%20Science&amp;o=rss002">Select Science</source>
    </item>
    <item>
      <title>Climate change makes agricultural biotechnology more relevant - DA</title>
      <link>http://c.moreover.com/click/here.pl?r2348253720</link>
      <description>change make research and development of more 'superior' crops that grow faster, bigger and produce higher yields, more relevant, an agriculture official disclosed. Advances in agricultural biotechnology should focus more on the development of climate</description>
      <guid>http://c.moreover.com/click/here.pl?r2348253720</guid>
      <pubDate>Fri, 20 Nov 2009 17:36:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Truth%20About%20Trade&amp;o=rss002">Truth About Trade</source>
    </item>
    <item>
      <title>Straight talk on GM crops crucial</title>
      <link>http://c.moreover.com/click/here.pl?r2348252532</link>
      <description>The planting of genetically modified (GM) crops is an issue that deserves discussion, because there are good arguments both for and against. Today, however, this has become a global trend, with GM crops being planted over large areas in a growing number</description>
      <guid>http://c.moreover.com/click/here.pl?r2348252532</guid>
      <pubDate>Fri, 20 Nov 2009 17:35:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Truth%20About%20Trade&amp;o=rss002">Truth About Trade</source>
    </item>
    <item>
      <title>Zimbabwe Farmers Calls for Planting of GMOs</title>
      <link>http://c.moreover.com/click/here.pl?r2348247266</link>
      <description>Zimbabwe - Harare - The Zimbabwe Commercial Farmers Union (ZCFU) has called on the Government to allow farmers to plant Genetically Modified Organisms (GMOs) maize seed so as to increase harvest and counter imports. In a telephone interview yesterday,</description>
      <guid>http://c.moreover.com/click/here.pl?r2348247266</guid>
      <pubDate>Fri, 20 Nov 2009 17:33:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Truth%20About%20Trade&amp;o=rss002">Truth About Trade</source>
    </item>
    <item>
      <title>UK: GM Crops Have A Role In Preventing World Hunger, Chief Scientist Says</title>
      <link>http://c.moreover.com/click/here.pl?r2348243845</link>
      <description>crops have a role to play in preventing mass starvation across the world caused by a combination of climate change and rapid population growth, a senior government scientist said yesterday. Professor Robert Watson, the chief scientific adviser at the</description>
      <guid>http://c.moreover.com/click/here.pl?r2348243845</guid>
      <pubDate>Fri, 20 Nov 2009 17:31:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Truth%20About%20Trade&amp;o=rss002">Truth About Trade</source>
    </item>
    <item>
      <title>Scientists have high hopes for corn genome</title>
      <link>http://c.moreover.com/click/here.pl?r2348236321</link>
      <description>If a biologist had to pick one living thing as the textbook of how genes work, what would it be? Corn seems to be a good answer. Now the scientific world has at hand the complete genome sequence of corn, announced by researchers who have collaborated</description>
      <guid>http://c.moreover.com/click/here.pl?r2348236321</guid>
      <pubDate>Fri, 20 Nov 2009 17:27:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Truth%20About%20Trade&amp;o=rss002">Truth About Trade</source>
    </item>
    <item>
      <title>HealthCor Urges Biogen Board Consider Number Of Changes</title>
      <link>http://c.moreover.com/click/here.pl?r2348235373</link>
      <description>NEW YORK -(Dow Jones)- HealthCor Management, a hedge fund that owns a 1.3% stake in Biogen Idec Inc. (BIIB), sent a letter to the biotech's board criticizing its spending, executive compensation and urging it to return cash to shareholders. The fund,</description>
      <guid>http://c.moreover.com/click/here.pl?r2348235373</guid>
      <pubDate>Fri, 20 Nov 2009 17:27:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Nasdaq&amp;o=rss002">Nasdaq</source>
    </item>
    <item>
      <title>Corn Genome Sequencing Complete</title>
      <link>http://c.moreover.com/click/here.pl?r2348226332</link>
      <description>Genome Sequencing Project, the first comprehensive gene map of North American Corn, will be made available to the public Friday by the National Corn Growers Association. Publication of these results marks the end of over a decade-long collaboration</description>
      <guid>http://c.moreover.com/click/here.pl?r2348226332</guid>
      <pubDate>Fri, 20 Nov 2009 17:23:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=California%20Farmer&amp;o=rss002">California Farmer</source>
    </item>
    <item>
      <title>Corn Genome Sequencing Complete</title>
      <link>http://c.moreover.com/click/here.pl?r2348213970</link>
      <description>Scientists will develop real world applications from knowledge. Results of the Maize Genome Sequencing Project, the first comprehensive gene map of North American Corn, will be made available to the public Friday by the National Corn Growers Association.</description>
      <guid>http://c.moreover.com/click/here.pl?r2348213970</guid>
      <pubDate>Fri, 20 Nov 2009 17:18:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Southern%20Farmer&amp;o=rss002">Southern Farmer</source>
    </item>
    <item>
      <title>An Undervalued Biotech</title>
      <link>http://c.moreover.com/click/here.pl?r2348203371</link>
      <description>Antisoma is fully funded and has three potential blockbusters. I have a soft spot for life sciences companies that combine strong balance sheets with products facing the final hurdle (phase III trials). In the last year I have looked at Renova (LSE:</description>
      <guid>http://c.moreover.com/click/here.pl?r2348203371</guid>
      <pubDate>Fri, 20 Nov 2009 17:14:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Fool.co.uk&amp;o=rss002">Fool.co.uk</source>
    </item>
    <item>
      <title>Scientists complete corn genome</title>
      <link>http://c.moreover.com/click/here.pl?r2348184636</link>
      <description>The maize (corn) genome sequence is now complete. Iowa State University (ISU) Plant Sciences Institute (PSI) researchers developed methods for the assembly of sequence data and conducted much of the ongoing functional analysis work as part of a</description>
      <guid>http://c.moreover.com/click/here.pl?r2348184636</guid>
      <pubDate>Fri, 20 Nov 2009 17:06:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Agriculture%20Online&amp;o=rss002">Agriculture Online</source>
    </item>
    <item>
      <title>An Undervalued Biotech</title>
      <link>http://c.moreover.com/click/here.pl?r2348182404</link>
      <description>Antisoma is fully funded and has three potential blockbusters. I have a soft spot for life sciences companies that combine strong balance sheets with products facing the final hurdle (phase III trials). In the last year I have looked at Renova (LSE:</description>
      <guid>http://c.moreover.com/click/here.pl?r2348182404</guid>
      <pubDate>Fri, 20 Nov 2009 17:05:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Motley%20Fool%20UK&amp;o=rss002">Motley Fool UK</source>
    </item>
    <item>
      <title>New Ex-Cell® Antifoam From SAFC Biosciences Increases Consistency in Cell Culture Manufacturing</title>
      <link>http://c.moreover.com/click/here.pl?r2348169935</link>
      <description>SAFC Biosciences® announces the introduction of EX-CELL ANTIFOAM, a non-animal origin solution that enhances foam control in cell culture bioreactors to increase the consistency, efficiency and stability in cell culture manufacturing. The EX-CELL</description>
      <guid>http://c.moreover.com/click/here.pl?r2348169935</guid>
      <pubDate>Fri, 20 Nov 2009 16:59:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Select%20Science&amp;o=rss002">Select Science</source>
    </item>
    <item>
      <title>DNA Probes-Based Diagnostics - A Worldwide Market Review - New Report Published</title>
      <link>http://c.moreover.com/click/here.pl?r2348166660</link>
      <description> New report provides detailed analysis of the Healthcare and Medical market Published on November 20, 2009by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND  DNA probes-based diagnostics is an emerging application area in the</description>
      <guid>http://c.moreover.com/click/here.pl?r2348166660</guid>
      <pubDate>Fri, 20 Nov 2009 16:57:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=OfficialSpin&amp;o=rss002">OfficialSpin</source>
    </item>
    <item>
      <title>USDA scientists, colleagues sequence corn genome -- largest plant genome to date</title>
      <link>http://c.moreover.com/click/here.pl?r2348147334</link>
      <description>WASHINGTON, D.C. -- USDA scientists and their colleagues have completed a four-year effort to sequence the genome of corn, an achievement expected to speed up development of corn varieties that will help feed the world and meet growing demands for using</description>
      <guid>http://c.moreover.com/click/here.pl?r2348147334</guid>
      <pubDate>Fri, 20 Nov 2009 16:49:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=AgProfessional&amp;o=rss002">AgProfessional</source>
    </item>
    <item>
      <title>Arcadia Biosciences, Vilmoran form alliance to develop and market Nitrogen Use Efficient wheat</title>
      <link>http://c.moreover.com/click/here.pl?r2348146754</link>
      <description>DAVIS, Calif. and PARIS -- Arcadia Biosciences Inc. and Vilmorin today announced that they have reached an agreement for the development and commercialization of Nitrogen Use Efficient wheat. Under the terms of the agreement, Vilmorin receives privileged</description>
      <guid>http://c.moreover.com/click/here.pl?r2348146754</guid>
      <pubDate>Fri, 20 Nov 2009 16:49:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=AgProfessional&amp;o=rss002">AgProfessional</source>
    </item>
    <item>
      <title>BIO disputes report's arguments; says U.S. farmers continue to favor biotech crops</title>
      <link>http://c.moreover.com/click/here.pl?r2348136928</link>
      <description>WASHINGTON, D.C. -- American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996 because of the tangible benefits that biotech varieties deliver, the Biotechnology Industry Organization says. According to the</description>
      <guid>http://c.moreover.com/click/here.pl?r2348136928</guid>
      <pubDate>Fri, 20 Nov 2009 16:44:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=AgProfessional&amp;o=rss002">AgProfessional</source>
    </item>
    <item>
      <title>Genzyme Announces Results Of Phase 2/3 Trial Of Advanced Phosphate Binder</title>
      <link>http://c.moreover.com/click/here.pl?r2348133573</link>
      <description>Genzyme Corporation (Nasdaq: GENZ) reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB</description>
      <guid>http://c.moreover.com/click/here.pl?r2348133573</guid>
      <pubDate>Fri, 20 Nov 2009 16:43:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Medical%20News%20Today&amp;o=rss002">Medical News Today</source>
    </item>
    <item>
      <title>Is bad-news Genzyme paying CEO too much?</title>
      <link>http://c.moreover.com/click/here.pl?r2348102137</link>
      <description>When a company hits the skids, fingers start to point. And lately, fingers have been pointing pretty forcefully at Henri Termeer ( photo ), CEO of the ill-fated company Genzyme. Naturally, inquiring minds want to know how Termeer has fared financially as</description>
      <guid>http://c.moreover.com/click/here.pl?r2348102137</guid>
      <pubDate>Fri, 20 Nov 2009 16:32:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=FiercePharma&amp;o=rss002">FiercePharma</source>
    </item>
    <item>
      <title>EFT Biotech Holdings To Make Institutional Presentation Throughout Europe</title>
      <link>http://c.moreover.com/click/here.pl?r2348084451</link>
      <description>y IRW-Press(IRW-Press and OfficialWire)CITY OF INDUSTRY, CA  EFT BioTech Holdings, Inc., (OTC: EFTB.PK) a proprietary e-commerce solutions company providing 'made in the USA' health, beauty and nutraceutical products under the EFT brand to its affiliate</description>
      <guid>http://c.moreover.com/click/here.pl?r2348084451</guid>
      <pubDate>Fri, 20 Nov 2009 16:25:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=OfficialSpin&amp;o=rss002">OfficialSpin</source>
    </item>
    <item>
      <title>ImmunoGen bags second $35M deal with Amgen</title>
      <link>http://c.moreover.com/click/here.pl?r2348076393</link>
      <description>ImmunoGen today announced its second licensing deal with Amgen in three months. The biotech giant gains rights to ImmunoGen's maytansinoid Targeted Antibody Payload (TAP) technology, which uses antibodies to deliver a cancer cell-killing agent, to</description>
      <guid>http://c.moreover.com/click/here.pl?r2348076393</guid>
      <pubDate>Fri, 20 Nov 2009 16:22:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=FierceBiotech&amp;o=rss002">FierceBiotech</source>
    </item>
  </channel>
</rss>
 